Clear all filters Results are currently filtered by:
3 November 2017
The Guild is actively lobbying Health Minister Hunt to address the issue of direct supply by manufacturers by advocating that all PBS medicines be made available to pharmacies through the full line wholesalers.
20 October 2017
Community Pharmacy 2025 Strategic Adviser appointed; Guild and PSA collaborate on codeine training and materials; real time recording in Victoria; Location Rules legislation in Federal Parliament.
13 October 2017
This week the Federal Court upheld the Fair Work Commission’s penalty rates decision, rejecting an appeal by the unions United Voice and SDA.
6 October 2017
When we put our solution to the politicians they think it makes sense, particularly when we explain how up-scheduling alone will mean a loss of convenience and higher costs for patients, as well as the clogging up of GP practices…
29 September 2017
Guild National President George Tambassis spoke with Minister Hunt last week, making clear that pharmacy can play a key role in this significant health reform.
15 September 2017
Members may have seen some information in our Forefront online publication this week introducing a project we are embarking on titled Community Pharmacy 2025, or CP2025.
8 September 2017
The Guild was well represented at the Nationals conference in Canberra. Members are also advised that the voting period for Stage 2 of the Guild elections has been extended.
21 August 2017
This week the Guild has issued guidance on the expected impact of the 1 October PBS price disclosure reductions.
7 July 2017
In every State and Territory, the pharmacy ownership rules prohibit anyone other than a registered pharmacist from owning a community pharmacy.While the laws differ slightly between jurisdictions, their intent is the same. Lawmakers around Australia have made clear that pharmacists…
9 June 2017
The Guild is now focused on the transition to prescription-only codeine products from February next year – with an emphasis on advocacy for an alternative way to keep these medicines available through community pharmacy, patient education, and pharmacy business responses.